文章 10：Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease
唐氏综合症患者血液中β-淀粉样蛋白和 tau 蛋白与阿尔茨海默病的比较
文章 11：Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
文章 12：Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment
血管性认知障碍患者血浆中β-淀粉样蛋白和 tau 蛋白含量之研究
文章 13：Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
文章 14：Alzheimer's disease and blood-based biomarkers – potential contexts of use
文章 15：Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
免疫磁还原法检测血浆生物标志物：早期诊断阿尔茨海默病的一种前瞻性方法
文章 16：Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
血浆 ps129-α-synuclein 是帕金森病运动严重程度和进展的代用品
文章 17：Plasma Aβ42 and Total Tau Predict Cognitive Decline in Amnestic Mild Cognitive Impairment
血浆 aβ42 和总 tau 能预测遗忘性轻度认知损害的认知功能下降
文章 18：Plasma Aβ analysis using magnetically-labeled immunoassays and PET F-florbetapir binding in non-demented patients with major depressive disorder.
磁标记免疫分析和 PET-氟哌啶醇结合分析非痴呆抑郁症患者血漿中的 aβ
相关阅读：
题图来源：站酷海洛